Analyst Upgrades: TASER International, Inc., Shake Shack Inc, and Humana Inc

Analysts upwardly revised their ratings and price targets on TASER International, Inc. (NASDAQ:TASR), Shake Shack Inc (NYSE:SHAK), and Humana Inc (NYSE:HUM)

Nov 10, 2016 at 9:14 AM
facebook twitter linkedin


Analysts are weighing in on stun gun producer TASER International, Inc. (NASDAQ:TASR), burger joint Shake Shack Inc (NYSE:SHAK), and insurance stock Humana Inc (NYSE:HUM). Here's a quick roundup of today's bullish brokerage notes for TASR, SHAK, and HUM.

  • TASR is set to rally thanks to the company's better-than-expected earnings results. The shares are up 7% ahead of the open, as Craig-Hallum and J.P. Morgan Securities increased their respective price targets to $35 and $32 -- both in annual-high territory. Though TASER International, Inc. has pulled back since flirting with the $30 mark back in August, the shares recently found firm support from their 200-day and 320-day moving averages, closing Wednesday at $23.67. Short sellers, meanwhile, may be reconsidering their positions. Short interest represents more than one-fifth of the stock's float, and equals one week's worth of buying power, at TASR's average daily volumes. 
  • SHAK is also set for a post-earnings burst, with the shares gaining 10% in pre-market action, after the company posted a third-quarter profit that blew past estimates, while also raising its full-year revenue outlook. Shake Shack Inc was in need of a positive development, with shareholders watching the stock dive 22.5% since its most recent high of $42.94 in August, last seen at $33.26. Turning to the analyst front, most are bearish on SHAK, with just four of 11 recommending investors buy the stock. Overnight, though, Wedbush raised its price target to $30, and Jefferies bumped its price target to $38. 
  • It's truly been an up-and-down year for HUM, rising to $190 in June, only to fall to $150 weeks later, with several large moves coming before and after. In fact, the shares have gained 11% this week alone to trade at $186 -- avoiding the broader healthcare swoon in the process -- and have edged 1.1% higher ahead of the open yet again. Helping Humana Inc this morning is an upgrade to "overweight" from "neutral" at J.P. Morgan Securities, which also raised its price target to $202 from $163, representing an annual high. In the meantime, options traders have been bracing for a pullback. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), HUM has posted a 10-day put/call volume ratio of 9.36, ranking in the high 88th annual percentile. 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

Winning With Weekly Options

1606854690

  


 
Special Offers from Schaeffer's Trading Partners